Samantha M. Grist
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samantha M. Grist has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Lukas Chrostowski
Department of Electrical and Computer Engineering, University of British Columbia, 5500-2332 Main Mall, Vancouver, BC V6T 1Z4, Canada
17 shared publicationsJonas Flueckiger
Department of Electrical and Computer Engineering, University of British Columbia, Canada
11 shared publicationsKaren C. Cheung
School of Biomedical Engineering, University of British Columbia, 251-2222 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada
9 shared publications- Karen C. Cheung
School of Biomedical Engineering, University of British Columbia, 251-2222 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada
8 shared publications - Amy Elizabeth Herr
Department of Bioengineering, University of California Berkeley, Berkeley, California 94720, United States
6 shared publications Nicolas A. F. Jaeger
Department of Electrical and Computer Engineering, The University of British Columbia 2332 Main Mall, Vancouver, BC, V6T 1Z4 Canada
6 shared publications
Latest Publications
- Open Access
Multiplexed hormone immunoassays for women’s health on a regenerable silicon photonic chip
Hormone dynamics are central to a multitude of conditions in women’s health; however, limitations in the cost, convenience, and multiplexing capacity of current hormone assays preclude routine longitudinal hormone testing. This limitation severely restricts our understanding in this historically neglected field, presenting a need for improved bioanalytical tools to support hormone-informed care. Silicon photonic resonator sensors have excellent multiplexing capacity and scalable fabrication, and offer strong potential to meet this important need. Here we demonstrate, for the first time, multiplexed silicon photonic detection of two urinary hormone biomarkers, follicle-stimulating hormone (FSH) and pregnanediol-3-glucuronide (PdG), using sub-wavelength grating ring resonators and a polydopamine-based, regenerable surface chemistry. We combine a sandwich immunoassay for FSH and an antigen-down competitive immunoassay for PdG on the same chip, both amplified using a commercially available quantum-dot–streptavidin conjugate and with on-chip regeneration over multiple measurement cycles. In artificial urine, this proof-of-principle multiplexed assay achieves limits of detection of 0.594 ng/mL for FSH and 19.1 ng/mL for PdG. This architecture is inherently scalable to tens of hormone targets on a millimetre-scale chip (a >10× multiplexing improvement over typical lateral-flow immunoassays) enabling future low-cost, quantitative at-home hormone panels that could transform research, diagnostics, and treatment in women’s health.
Open AccessMultiplexed hormone immunoassays for women’s health on a regenerable silicon photonic chip
Hormone dynamics are central to a multitude of conditions in women’s health; however, limitations in the cost, convenience, and multiplexing capacity of current hormone assays preclude routine longitudinal hormone testing. This limitation severely restricts our understanding in this historically neglected field, presenting a need for improved bioanalytical tools to support hormone-informed care. Silicon photonic resonator sensors have excellent multiplexing capacity and scalable fabrication, and offer strong potential to meet this important need. Here we demonstrate, for the first time, multiplexed silicon photonic detection of two urinary hormone biomarkers, follicle-stimulating hormone (FSH) and pregnanediol-3-glucuronide (PdG), using sub-wavelength grating ring resonators and a polydopamine-based, regenerable surface chemistry. We combine a sandwich immunoassay for FSH and an antigen-down competitive immunoassay for PdG on the same chip, both amplified using a commercially available quantum-dot–streptavidin conjugate and with on-chip regeneration over multiple measurement cycles. In artificial urine, this proof-of-principle multiplexed assay achieves limits of detection of 0.594 ng/mL for FSH and 19.1 ng/mL for PdG. This architecture is inherently scalable to tens of hormone targets on a millimetre-scale chip (a >10× multiplexing improvement over typical lateral-flow immunoassays) enabling future low-cost, quantitative at-home hormone panels that could transform research, diagnostics, and treatment in women’s health.
- Open Access
- 1 June 2026
- Published by AIP Publishing in APL Photonics
- Vol. 11 (6)
A segmented resonator architecture for fixed-wavelength silicon photonic biosensors with CMOS-driven, resonance-tracking readout
Decentralized diagnostic testing that is accurate, portable, quantitative, and capable of making multiple simultaneous measurements of different biomarkers at the point-of-need remains an important unmet need in the post-pandemic world. Resonator-based biosensors using silicon photonic integrated circuits are a promising technology to meet this need, as they can leverage (i) semiconductor manufacturing economies of scale, (ii) exquisite optical sensitivity, and (iii) the ability to integrate tens to hundreds of sensors on a millimeter-scale photonic chip. However, their application to decentralized testing has historically been limited by the expensive, bulky tunable lasers and alignment optics required for their readout. In this work, we realize, for the first time, a segmented sensor architecture that addresses this important challenge by facilitating resonance-tracking readout using a fixed-wavelength laser. The architecture incorporates an in-resonator phase shifter modulated by CMOS drivers to periodically sweep and acquire the resonance peak shifts, as well as a distinct high-sensitivity sensing region, maintaining high performance at a fraction of the cost and size. The segmented architecture comprises purpose-built resonator segments, with sensitivity dependent on the relative length and waveguide design in the sensing region, and improvements in quality factor and intrinsic limit of detection achievable using low-loss routing waveguides. We show, for the first time, that reading out the segmented sensor with a fixed-wavelength laser can offer similar performance to reading it out with the traditional tunable laser, demonstrating a system limit of detection of 6.1 ± 1.9 × 10−5 RIU as well as immunoassay-based detection of the SARS-CoV-2 spike protein. We anticipate that this sensor architecture will open the door to a new data-rich class of portable, accurate, multiplexed diagnostics for decentralized testing.
- 1 June 2026
- Published by AIP Publishing in APL Photonics
- Vol. 11 (6)
Open AccessA segmented resonator architecture for fixed-wavelength silicon photonic biosensors with CMOS-driven, resonance-tracking readout
Decentralized diagnostic testing that is accurate, portable, quantitative, and capable of making multiple simultaneous measurements of different biomarkers at the point-of-need remains an important unmet need in the post-pandemic world. Resonator-based biosensors using silicon photonic integrated circuits are a promising technology to meet this need, as they can leverage (i) semiconductor manufacturing economies of scale, (ii) exquisite optical sensitivity, and (iii) the ability to integrate tens to hundreds of sensors on a millimeter-scale photonic chip. However, their application to decentralized testing has historically been limited by the expensive, bulky tunable lasers and alignment optics required for their readout. In this work, we realize, for the first time, a segmented sensor architecture that addresses this important challenge by facilitating resonance-tracking readout using a fixed-wavelength laser. The architecture incorporates an in-resonator phase shifter modulated by CMOS drivers to periodically sweep and acquire the resonance peak shifts, as well as a distinct high-sensitivity sensing region, maintaining high performance at a fraction of the cost and size. The segmented architecture comprises purpose-built resonator segments, with sensitivity dependent on the relative length and waveguide design in the sensing region, and improvements in quality factor and intrinsic limit of detection achievable using low-loss routing waveguides. We show, for the first time, that reading out the segmented sensor with a fixed-wavelength laser can offer similar performance to reading it out with the traditional tunable laser, demonstrating a system limit of detection of 6.1 ± 1.9 × 10−5 RIU as well as immunoassay-based detection of the SARS-CoV-2 spike protein. We anticipate that this sensor architecture will open the door to a new data-rich class of portable, accurate, multiplexed diagnostics for decentralized testing.
- Open Access
- 4 November 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (22) , 6033-6062
Resonating with replicability: factors shaping assay yield and variability in microfluidics-integrated silicon photonic biosensors
A detailed quantification of sensor-, microfluidic channel-, and assay-level variability is presented for a microfluidics-integrated silicon photonic biosensor.
- 4 November 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (22) , 6033-6062
Open AccessResonating with replicability: factors shaping assay yield and variability in microfluidics-integrated silicon photonic biosensors
A detailed quantification of sensor-, microfluidic channel-, and assay-level variability is presented for a microfluidics-integrated silicon photonic biosensor.
- Open Access
What Could Go Wrong? Promoting Success by Planning for Failure in Label-Free Biosensor Assay Development
Label-free biosensors offer powerful platforms for detecting molecular interactions, but developing robust assays on these systems presents several challenges due to the complexity of the testing systems and intersection of disciplines. In this work, we describe a lightweight, 3-step experimental workflow supporting troubleshooting and root cause analysis that we developed during the design and optimization of silicon photonic biosensor assays in an academic research setting. Because such environments often lack the resources and formal quality-management infrastructure available in industry, our approach emphasizes practicality and ease of adoption. Drawing from our own assay failures and successes, we identify common failure modes, propose structured troubleshooting workflows, and provide case studies illustrating the application of established frameworks, including the Five Whys, the Plan-Do-Check-Act cycle, Open-Narrow-Close and the Ishikawa (fishbone) diagram. By applying this framework to our research, we increased our assay yield by a factor of 2, from ~45% to ~90%. This paper aims to support other teams engaged in label-free assay development by equipping them with practical tools and experimental best practices. Highlights: We doubled assay yield from ~45% to ~90% by planning for failure, not just success. Tailored troubleshooting frameworks help pinpoint and solve various assay failures. Applying innovative problem-solving to workflows accelerates biosensor development. Systematic troubleshooting improves assay development across a range of lab settings. A 3-step workflow highlighting what could go wrong supports continuous improvement.
Open AccessWhat Could Go Wrong? Promoting Success by Planning for Failure in Label-Free Biosensor Assay Development
Label-free biosensors offer powerful platforms for detecting molecular interactions, but developing robust assays on these systems presents several challenges due to the complexity of the testing systems and intersection of disciplines. In this work, we describe a lightweight, 3-step experimental workflow supporting troubleshooting and root cause analysis that we developed during the design and optimization of silicon photonic biosensor assays in an academic research setting. Because such environments often lack the resources and formal quality-management infrastructure available in industry, our approach emphasizes practicality and ease of adoption. Drawing from our own assay failures and successes, we identify common failure modes, propose structured troubleshooting workflows, and provide case studies illustrating the application of established frameworks, including the Five Whys, the Plan-Do-Check-Act cycle, Open-Narrow-Close and the Ishikawa (fishbone) diagram. By applying this framework to our research, we increased our assay yield by a factor of 2, from ~45% to ~90%. This paper aims to support other teams engaged in label-free assay development by equipping them with practical tools and experimental best practices. Highlights: We doubled assay yield from ~45% to ~90% by planning for failure, not just success. Tailored troubleshooting frameworks help pinpoint and solve various assay failures. Applying innovative problem-solving to workflows accelerates biosensor development. Systematic troubleshooting improves assay development across a range of lab settings. A 3-step workflow highlighting what could go wrong supports continuous improvement.
- 1 October 2021
- Published by Wiley in Photochemistry and Photobiology
- Vol. 98 (4) , 864-873
Optical Attenuators Extend Dynamic Range but Alter Angular Response of Planar Ultraviolet‐C Dosimeters
Effective ultraviolet‐C (UV‐C) decontamination protocols of N95 respirators require validation that the entire N95 surface receives sufficient dose. Photochromic indicators (PCIs) can accurately measure UV‐C dose on nonplanar surfaces, but often saturate below doses required to decontaminate porous, multilayered textiles like N95s. Here, we investigate the use of optical attenuators to extend PCI dynamic range while maintaining a near‐ideal angular response—critical for accurate measurements of uncollimated UV‐C. We show analytically that tuning attenuator refractive index, attenuation coefficient, and thickness can extend dynamic range, but compromises angular response unless the attenuator is an ideal diffuser. To investigate this tradeoff empirically, we stack PCIs behind model specular (floated borosilicate) and diffuse (polytetrafluoroethylene) attenuators, characterize the angular response, and evaluate on‐N95 UV‐C measurement accuracy within a decontamination system. Both attenuators increase PCI dynamic range >4×, but simultaneously introduce angle‐dependent transmittance, which causes location‐dependent underestimation of UV‐C dose. PCI‐borosilicate and PCI‐polytetrafluoroethylene stacks underreport true on‐N95 dose by (1) 14.7% and 3.6%, respectively, when near‐normal to the source lamp array, and (2) 40.8% and 19.8%, respectively, in a steeply sloped location. Overall, we demonstrate that while planar attenuators can increase PCI dynamic range, verifying near‐ideal angular response is critical for accurate UV‐C measurements.
- 1 October 2021
- Published by Wiley in Photochemistry and Photobiology
- Vol. 98 (4) , 864-873
Optical Attenuators Extend Dynamic Range but Alter Angular Response of Planar Ultraviolet‐C Dosimeters
Effective ultraviolet‐C (UV‐C) decontamination protocols of N95 respirators require validation that the entire N95 surface receives sufficient dose. Photochromic indicators (PCIs) can accurately measure UV‐C dose on nonplanar surfaces, but often saturate below doses required to decontaminate porous, multilayered textiles like N95s. Here, we investigate the use of optical attenuators to extend PCI dynamic range while maintaining a near‐ideal angular response—critical for accurate measurements of uncollimated UV‐C. We show analytically that tuning attenuator refractive index, attenuation coefficient, and thickness can extend dynamic range, but compromises angular response unless the attenuator is an ideal diffuser. To investigate this tradeoff empirically, we stack PCIs behind model specular (floated borosilicate) and diffuse (polytetrafluoroethylene) attenuators, characterize the angular response, and evaluate on‐N95 UV‐C measurement accuracy within a decontamination system. Both attenuators increase PCI dynamic range >4×, but simultaneously introduce angle‐dependent transmittance, which causes location‐dependent underestimation of UV‐C dose. PCI‐borosilicate and PCI‐polytetrafluoroethylene stacks underreport true on‐N95 dose by (1) 14.7% and 3.6%, respectively, when near‐normal to the source lamp array, and (2) 40.8% and 19.8%, respectively, in a steeply sloped location. Overall, we demonstrate that while planar attenuators can increase PCI dynamic range, verifying near‐ideal angular response is critical for accurate UV‐C measurements.
- Open Access
Nonuniform UV-C dose across N95 facepieces can cause 2.9-log variation in SARS-CoV-2 inactivation
During public health crises like the COVID-19 pandemic, ultraviolet-C (UV-C) decontamination of N95 respirators for emergency reuse has been implemented to mitigate shortages. However, decontamination efficacy across N95s is poorly understood, due to the dependence on received UV-C dose, which varies across the complex three-dimensional N95 shape. Robust quantification of UV-C dose across N95 facepieces presents challenges, as few UV-C measurement tools have sufficient 1) small, flexible form factor, and 2) angular response. To address this gap, we combine optical modeling and quantitative photochromic indicator (PCI) dosimetry with viral inactivation assays to generate high-resolution maps of “on-N95” UV-C dose and concomitant SARS-CoV-2 viral inactivation across N95 facepieces within a commercial decontamination chamber. Using modeling to rapidly identify on-N95 locations of interest, in-situ measurements report a 17.4 ± 5.0-fold dose difference across N95 facepieces in the chamber, yielding 2.9 ± 0.2-log variation in SARS-CoV-2 inactivation. UV-C dose at several on-N95 locations was lower than the lowest-dose locations on the chamber floor, highlighting the importance of on-N95 dose validation. Overall, we couple optical simulation with in-situ PCI dosimetry to relate UV-C dose and viral inactivation at specific on-N95 locations, informing the design of safe and effective decontamination protocols.
Open AccessNonuniform UV-C dose across N95 facepieces can cause 2.9-log variation in SARS-CoV-2 inactivation
During public health crises like the COVID-19 pandemic, ultraviolet-C (UV-C) decontamination of N95 respirators for emergency reuse has been implemented to mitigate shortages. However, decontamination efficacy across N95s is poorly understood, due to the dependence on received UV-C dose, which varies across the complex three-dimensional N95 shape. Robust quantification of UV-C dose across N95 facepieces presents challenges, as few UV-C measurement tools have sufficient 1) small, flexible form factor, and 2) angular response. To address this gap, we combine optical modeling and quantitative photochromic indicator (PCI) dosimetry with viral inactivation assays to generate high-resolution maps of “on-N95” UV-C dose and concomitant SARS-CoV-2 viral inactivation across N95 facepieces within a commercial decontamination chamber. Using modeling to rapidly identify on-N95 locations of interest, in-situ measurements report a 17.4 ± 5.0-fold dose difference across N95 facepieces in the chamber, yielding 2.9 ± 0.2-log variation in SARS-CoV-2 inactivation. UV-C dose at several on-N95 locations was lower than the lowest-dose locations on the chamber floor, highlighting the importance of on-N95 dose validation. Overall, we couple optical simulation with in-situ PCI dosimetry to relate UV-C dose and viral inactivation at specific on-N95 locations, informing the design of safe and effective decontamination protocols.
- Open Access
- 1 January 2021
- Published by National Institute of Standards and Technology (NIST) in Journal of Research of the National Institute of Standards and Technology
- Vol. 126
Best Practices for Germicidal Ultraviolet-C Dose Measurement for N95 Respirator Decontamination
Ultraviolet-C (UV-C) decontamination holds promise in combating the coronavirus disease 2019 pandemic, particularly with its potential to mitigate the N95 respirator shortage. Safe, effective, and reproducible decontamination depends critically on UV-C dose, yet dose is frequently measured and reported incorrectly, which results in misleading and potentially harmful protocols. Understanding best practices in UV-C dose measurement for N95 respirator decontamination is essential to the safety of medical professionals, researchers, and the public. Here, we outline the fundamental optical principles governing UV-C irradiation and detection, as well as the key metrics of UV-C wavelength and dose. In particular, we discuss the technical and regulatory distinctions between UV-C N95 respirator decontamination and other applications of germicidal UV-C, and we highlight the unique considerations required for UV-C N95 respirator decontamination. Together, this discussion will inform best practices for UV-C dose measurement for N95 respirator decontamination during crisis-capacity conditions.
- 1 January 2021
- Published by National Institute of Standards and Technology (NIST) in Journal of Research of the National Institute of Standards and Technology
- Vol. 126
Open AccessBest Practices for Germicidal Ultraviolet-C Dose Measurement for N95 Respirator Decontamination
Ultraviolet-C (UV-C) decontamination holds promise in combating the coronavirus disease 2019 pandemic, particularly with its potential to mitigate the N95 respirator shortage. Safe, effective, and reproducible decontamination depends critically on UV-C dose, yet dose is frequently measured and reported incorrectly, which results in misleading and potentially harmful protocols. Understanding best practices in UV-C dose measurement for N95 respirator decontamination is essential to the safety of medical professionals, researchers, and the public. Here, we outline the fundamental optical principles governing UV-C irradiation and detection, as well as the key metrics of UV-C wavelength and dose. In particular, we discuss the technical and regulatory distinctions between UV-C N95 respirator decontamination and other applications of germicidal UV-C, and we highlight the unique considerations required for UV-C N95 respirator decontamination. Together, this discussion will inform best practices for UV-C dose measurement for N95 respirator decontamination during crisis-capacity conditions.
- Open Access
- 4 December 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-17
3D projection electrophoresis for single-cell immunoblotting
Immunoassays and mass spectrometry are powerful single-cell protein analysis tools; however, interfacing and throughput bottlenecks remain. Here, we introduce three-dimensional single-cell immunoblots to detect both cytosolic and nuclear proteins. The 3D microfluidic device is a photoactive polyacrylamide gel with a microwell array-patterned face (xy) for cell isolation and lysis. Single-cell lysate in each microwell is “electrophoretically projected” into the 3rd dimension (z-axis), separated by size, and photo-captured in the gel for immunoprobing and confocal/light-sheet imaging. Design and analysis are informed by the physics of 3D diffusion. Electrophoresis throughput is > 2.5 cells/s (70× faster than published serial sampling), with 25 immunoblots/mm2 device area (>10× increase over previous immunoblots). The 3D microdevice design synchronizes analyses of hundreds of cells, compared to status quo serial analyses that impart hours-long delay between the first and last cells. Here, we introduce projection electrophoresis to augment the heavily genomic and transcriptomic single-cell atlases with protein-level profiling.
- 4 December 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-17
Open Access3D projection electrophoresis for single-cell immunoblotting
Immunoassays and mass spectrometry are powerful single-cell protein analysis tools; however, interfacing and throughput bottlenecks remain. Here, we introduce three-dimensional single-cell immunoblots to detect both cytosolic and nuclear proteins. The 3D microfluidic device is a photoactive polyacrylamide gel with a microwell array-patterned face (xy) for cell isolation and lysis. Single-cell lysate in each microwell is “electrophoretically projected” into the 3rd dimension (z-axis), separated by size, and photo-captured in the gel for immunoprobing and confocal/light-sheet imaging. Design and analysis are informed by the physics of 3D diffusion. Electrophoresis throughput is > 2.5 cells/s (70× faster than published serial sampling), with 25 immunoblots/mm2 device area (>10× increase over previous immunoblots). The 3D microdevice design synchronizes analyses of hundreds of cells, compared to status quo serial analyses that impart hours-long delay between the first and last cells. Here, we introduce projection electrophoresis to augment the heavily genomic and transcriptomic single-cell atlases with protein-level profiling.
- 26 August 2020
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 12 (38) , 4638-4648
Rapid electrotransfer probing for improved detection sensitivity in in-gel immunoassays
This study demonstrates electrotransfer probing for improved protein detection sensitivity of hydrogel-based immunoassays in reduced time compared to conventional diffusive probing.
- 26 August 2020
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 12 (38) , 4638-4648
Rapid electrotransfer probing for improved detection sensitivity in in-gel immunoassays
This study demonstrates electrotransfer probing for improved protein detection sensitivity of hydrogel-based immunoassays in reduced time compared to conventional diffusive probing.
- Open Access
UV-C decontamination for N95 emergency reuse: Quantitative dose validation with photochromic indicators
With COVID-19 N95 respirator shortages, frontline medical personnel are forced to reuse this disposable – but sophisticated – multilayer textile respirator. Widely used for decontamination of nonporous surfaces, UV-C light has germicidal efficacy on porous, non-planar N95 respirators when ≥1.0 J/cm 2 dose is applied across all surfaces. Here, we address outstanding limitations of photochromic indicators (qualitative readout and insufficient dynamic range) and introduce a photochromic UV-C dose quantification technique for: (1) design of UV-C treatments and (2) in-process UV-C dose validation. Our methodology establishes that color-changing dosimetry can achieve the necessary accuracy (>90%), uncertainty (95%). Furthermore, we adapt consumer electronics for accessible quantitative readout and extend the dynamic range >10× using optical attenuators. In a measurement infeasible with radiometers, we observe striking 20× dose variation over 3D N95 facepieces. By transforming photochromic indicators into quantitative dosimeters, we illuminate critical design considerations for both photochromic indicators and UV-C decontamination.
Open AccessUV-C decontamination for N95 emergency reuse: Quantitative dose validation with photochromic indicators
With COVID-19 N95 respirator shortages, frontline medical personnel are forced to reuse this disposable – but sophisticated – multilayer textile respirator. Widely used for decontamination of nonporous surfaces, UV-C light has germicidal efficacy on porous, non-planar N95 respirators when ≥1.0 J/cm 2 dose is applied across all surfaces. Here, we address outstanding limitations of photochromic indicators (qualitative readout and insufficient dynamic range) and introduce a photochromic UV-C dose quantification technique for: (1) design of UV-C treatments and (2) in-process UV-C dose validation. Our methodology establishes that color-changing dosimetry can achieve the necessary accuracy (>90%), uncertainty (95%). Furthermore, we adapt consumer electronics for accessible quantitative readout and extend the dynamic range >10× using optical attenuators. In a measurement infeasible with radiometers, we observe striking 20× dose variation over 3D N95 facepieces. By transforming photochromic indicators into quantitative dosimeters, we illuminate critical design considerations for both photochromic indicators and UV-C decontamination.